PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder
Open Access
- 12 August 2010
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 14 (02) , 237-245
Abstract
Variant rs2522833 of the Piccolo-encoding gene PCLO has recently been found to be associated with major depressive disorder (MDD). PCLO encodes a preKeywords
This publication has 32 references indexed in Scilit:
- The PCLO gene and depressive disorders: replication in a population-based studyHuman Molecular Genetics, 2009
- Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant TreatmentNeuropsychopharmacology, 2009
- Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccoloMolecular Psychiatry, 2008
- Unipolar depression and hippocampal volume: Impact of DNA sequence variants of the glucocorticoid receptor geneAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatmentAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2007
- The Molecular Neurobiology of DepressionPsychiatric Clinics of North America, 2007
- Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatmentNature Genetics, 2004
- The Corticosteroid Receptor Hypothesis of DepressionNeuropsychopharmacology, 2000
- GPOWER: A general power analysis programBehavior Research Methods, Instruments, & Computers, 1996
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960